Post-neoadjuvant treatment of breast cancer

Post-neoadjuvant treatment of breast cancer

Achieving a pathologic complete response as a result of neoadjuvant treatment is associated with improved prognosis in breast cancer. The CREATE-X trial showed a significant survival improvement with capecitabine treatment of patients with residual invasive disease following neoadjuvant chemotherapy...

Full description

Bibliographic Details
Main Authors:	V. F. Semiglazov, M. A. Dzhelialova, S. S. Yerechshenko, E. T. Munaeva, R. S. Pesotsky, A. I. Tseluyko, A. S. Emelyanov, R. V. Donskikh, P. V. Krivorotko
Format:	Article
Language:	Russian
Published:	Remedium Group LLC 2020-07-01
Series:	Медицинский совет
Subjects:	breast cancer post-neoadjuvant treatment neoadjuvant systemic therapy residual invasive tumor potential biomarkers
Online Access:	https://www.med-sovet.pro/jour/article/view/5740

Similar Items

Neoadjuvant treatment for breast cancer
by: V. F. Semiglazov, et al.
Published: (2014-07-01)

The main markers of the long-term efficiency of neoadjuvant chemotherapy in breast cancer (review of literature)
by: V F Semiglazov, et al.
Published: (2013-12-01)

NEOADJUVANT ENDOCRINE THERAPY FOR PATIENTS WITH ESTROGEN-RECEPTOR-POSITIVE BREAST CANCER
by: V. F. Semiglazov, et al.
Published: (2018-07-01)

Strategy of post-neoadjuvant treatment of patients with residual breast cancer
by: V. V. Semiglazov, et al.
Published: (2020-06-01)

Correlation of the value of sonoelastography strain ratio with the degree of pathological regression in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy
by: E. A. Bus’ko, et al.
Published: (2017-02-01)

Breast cancer biomarker (ER, PR, HER2) changes in the phenotype after neoadjuvant treatment
by: V. O. Bashlyk, et al.
Published: (2018-07-01)

Effect of neoadjuvant therapy on breast cancer biomarker profile
by: Laura Rey-Vargas, et al.
Published: (2020-07-01)

Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer
by: Hyder T, et al.
Published: (2021-03-01)

Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer
by: Andrew McGuire, et al.
Published: (2020-07-01)

Identification of the plasma total cfDNA level before and after chemotherapy as an indicator of the neoadjuvant chemotherapy response in locally advanced breast cancer
by: Ge Ma, et al.
Published: (2020-04-01)

Diagnostic accuracy of MRI to evaluate tumour response and residual tumour size after neoadjuvant chemotherapy in breast cancer patients
by: Bouzón Alberto, et al.
Published: (2016-02-01)

Magnetic resonance imaging in evaluation of efficiency of neoadjuvant chemotherapy of breast cancer
by: A. V. Komyahov, et al.
Published: (2015-12-01)

Neoadjuvant chemotherapy for primary sarcoma of the breast: a case report
by: Chieko Miyazaki, et al.
Published: (2019-09-01)

COMPARATIVE ANALYSIS OF DIFFERENT NEOADJUVANT CHEMOTHERAPY REGIMENS FOR TRIPLE-NEGATIVE BREAST CANCER
by: P. V. Krivorotko, et al.
Published: (2017-12-01)

Serum levels of VEGF and MCSF in HER2+ / HER2- breast cancer patients with metronomic neoadjuvant chemotherapy
by: Roberto J. Arai, et al.
Published: (2018-06-01)

Neoadjuvant Chemotherapy Alters Neuropilin-1, PlGF, and SNAI1 Expression Levels and Predicts Breast Cancer Patients Response
by: Noura Al-Zeheimi, et al.
Published: (2019-04-01)

The tumour response of postmenopausal hormone receptor-positive breast cancers undergoing different types of neoadjuvant therapy: a meta-analysis
by: Yaling Wang, et al.
Published: (2020-01-01)

Triple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment
by: da Silva JL, et al.
Published: (2021-01-01)

Tumor Microenvironment Characterization in Breast Cancer Identifies Prognostic and Neoadjuvant Chemotherapy Relevant Signatures
by: Fei Ji, et al.
Published: (2021-10-01)

Effect of preoperative Xiaoaiping combined with TEC neoadjuvant chemotherapy on malignant biological behaviors of breast cancer cells
by: Qin Yang, et al.
Published: (2018-10-01)

Mirna21 Expression in the Breast Cancer Tumor Tissue is Independent of Neoadjuvant Chemotherapy
by: Sales ACV, et al.
Published: (2020-10-01)

Impact of various options of neoadjuvant chemotherapy on the hormonal status of patients with breast cancer
by: Yu. S. Sidorenko, et al.
Published: (2014-08-01)

Does tumor stroma ratio of breast cancer trucut biopsy determine response to neoadjuvant therapy?
by: Varuna Mallya, et al.
Published: (2020-01-01)

Association of Ki-67 Expression and Response of Neoadjuvant Chemotherapy in Invasive Breast Cancer Patients in Bandung
by: Andri Rezano, et al.
Published: (2018-09-01)

Evaluation of the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer
by: Wang H, et al.
Published: (2020-06-01)

Diffusion weighted imaging in early prediction of neoadjuvant chemotherapy response in breast cancer
by: Eman Abd Elrahim Mohamed El bakoury, et al.
Published: (2017-06-01)

Time course of changes in 6-sulfatoxymelatonin excretion in patients with breast cancer after various neoadjuvant chemotherapy options
by: Yu. S. Sidorenko, et al.
Published: (2014-07-01)

Resistance to Neoadjuvant Treatment in Breast Cancer: Clinicopathological and Molecular Predictors
by: María Rosario Chica-Parrado, et al.
Published: (2020-07-01)

Evaluation of tumor malignancy in patients with HER-2 overexpression breast cancer after TCH and TAC neoadjuvant chemotherapy
by: Yong Zhou, et al.
Published: (2016-10-01)

Blood cellular markers of inflammation in Breast Cancer and response to Neoadjuvant Chemotherapy
by: Babatunde Ayoade, et al.
Published: (2019-06-01)

NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer
by: Samuel A. Jacobs, et al.
Published: (2019-12-01)

Neoadjuvant Endocrine Therapy in Breast Cancer Management: State of the Art
by: Florence Lerebours, et al.
Published: (2021-02-01)

Predictors of Neoadjuvant Chemotherapy Response in Breast Cancer: A Review
by: Xu W, et al.
Published: (2020-06-01)

New Advances in the Research of Resistance to Neoadjuvant Chemotherapy in Breast Cancer
by: Junsha An, et al.
Published: (2021-09-01)

The Present and Future of Neoadjuvant Endocrine Therapy for Breast Cancer Treatment
by: Covadonga Martí, et al.
Published: (2021-05-01)

Neoadjuvant hormonal therapy is associated with comparable outcomes to neoadjuvant chemotherapy in post-menopausal women with estrogen receptor-positive breast cancer
by: David M. Marcus, et al.
Published: (2013-12-01)

Prognostic Nutritional Index (PNI) in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy as a Useful Prognostic Indicator
by: Li Chen, et al.
Published: (2021-03-01)

History and current situation of neoadjuvant treatment for locally advanced esophageal cancer
by: Junyi Li, et al.
Published: (2021-09-01)

Efficacy of neoadjuvant endocrine therapy compared with neoadjuvant chemotherapy in pre-menopausal patients with oestrogen receptor-positive and HER2-negative, lymph node-positive breast cancer
by: Hee Jeong Kim, et al.
Published: (2020-05-01)

Predictive molecular markers of resistance to chemotherapy in breast cancer
by: Valerian Cucieru
Published: (2021-03-01)